Bristol Hospice has acquired the Utah and California locations of Sojourn Hospice & Palliative Care, a Healthy Living Network company, for an undisclosed amount. Bristol Hospice is a portfolio company of the investment firm Webster Equity Partners.

The acquired operations include eight Sojourn locations that will rebrand as Bristol Hospice. As part of the transaction, Sojourn’s parent company the Healthy Living Network absorbed Bristol’s home health operations in Salt Lake City and Porterville, Calif.

“Sojourn Hospice & Palliative Care has a reputation for delivering exceptional patient care that closely models Bristol Hospice,” said Hyrum Kirton, CEO of Bristol Hospice.”We are excited to have acquired such bright, talented and mission-driven employees. Bristol Hospice has seen considerable growth over the past three years and will continue to expand services where we can make a difference.”

Bristol has completed nine acquisitions since Webster Equity Partners purchased the company in 2017 for $70 million. Bristol has made three acquisitions this year, including New Dawn Hospice near Dallas in Texas for an undisclosed sum.

Bristol operates 27 locations in eight states under the brands Bristol Hospice, Optimal Health Services and Suncrest Hospice of Colorado.

“We recognize the exceptional reputation and deep commitment to care that Bristol Hospice represents for our patients and employees going forward. We are comforted in knowing that our team members in our locations across California will benefit from Bristol’s unique aide services and dementia care programs,” Julio Quiñones, CEO of Healthy Living Network, said. “We are likewise excited to welcome the Bristol Home Health team and its patients into our network, where we will continue to deliver the highest quality of compassionate care.”

Hospice utilization runs high in the markets in which Sojourn operates. Utah has the highest utilization rate in the nation among Medicare decedents at 59.4%, according to the National Hospice & Palliative Care Organization. Utilization in California hovers around 42.5%.

This article originally appeared in an article in HospiceNews.